Cargando…
Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
Acute lung injury (ALI) is a severe disease that presents serious damage and excessive inflammation in lungs with high mortality without effective pharmacological therapy. Fluorofenidone (AKFPD) is a novel pyridone agent that has anti-fibrosis, anti-inflammation, and other pharmacological activities...
Autores principales: | Lv, Xin, Yao, Tingting, He, Rongling, He, Yijun, Li, Mengyu, Han, Yuanyuan, Zhang, Yan, Long, Lingzhi, Jiang, Guoliang, Cheng, Xiaoyun, Xie, Yanyun, Huang, Ling, Peng, Zhangzhe, Hu, Gaoyun, Li, Qianbin, Tao, Lijian, Meng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721041/ https://www.ncbi.nlm.nih.gov/pubmed/34987397 http://dx.doi.org/10.3389/fphar.2021.772031 |
Ejemplares similares
-
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
por: Dai, Qin, et al.
Publicado: (2020) -
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021) -
Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage
por: Liao, Xiaohua, et al.
Publicado: (2022) -
Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways
por: Peng, Yu, et al.
Publicado: (2019) -
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway
por: Song, Cheng, et al.
Publicado: (2016)